# Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

> **NCT02234297** · PHASE1 · COMPLETED · sponsor: **Blaze Bioscience Inc.** · enrollment: 17 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** BLZ-100

## Key facts

- **NCT ID:** NCT02234297
- **Lead sponsor:** Blaze Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234297, "Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02234297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*